E. Guttman-yassky, K. E. Nograles, and J. G. Krueger, Contrasting pathogenesis of atopic dermatitis and psoriasis???Part I: Clinical and pathologic concepts, Journal of Allergy and Clinical Immunology, vol.127, issue.5, pp.1110-1118, 2011.
DOI : 10.1016/j.jaci.2011.01.053

F. O. Nestle, D. H. Kaplan, and J. Barker, Psoriasis, New England Journal of Medicine, vol.361, issue.5, pp.496-509, 2009.
DOI : 10.1056/NEJMra0804595

F. X. Bernard, F. Morel, M. Camus, N. Pedretti, C. Barrault et al., Keratinocytes under Fire of Proinflammatory Cytokines: Bona Fide Innate Immune Cells Involved in the Physiopathology of Chronic Atopic Dermatitis and Psoriasis, Journal of Allergy, vol.10, issue.1, pp.718725-718726, 2012.
DOI : 10.1056/NEJMoa1104200

C. Haider, A. S. Bowman, and E. P. , Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells, J. Invest. Dermatol, vol.128, pp.1207-1211, 2008.

N. J. Wilson, K. Boniface, J. R. Chan, B. S. Mckenzie, W. M. Blumenschein et al., Development, cytokine profile and function of human interleukin 17???producing helper T cells, Nature Immunology, vol.176, issue.9, pp.950-957, 2007.
DOI : 10.4049/jimmunol.176.2.1098

F. Villanova, B. Flutter, I. Tosi, K. Grys, H. Sreeneebus et al., Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis, Journal of Investigative Dermatology, vol.134, issue.4
DOI : 10.1038/jid.2013.477

G. G. Krueger, R. G. Langley, C. Leonardi, N. Yeilding, C. Guzzo et al., A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis, New England Journal of Medicine, vol.356, issue.6, pp.580-592, 2007.
DOI : 10.1056/NEJMoa062382

C. A. Dinarello, Immunological and Inflammatory Functions of the Interleukin-1 Family, Annual Review of Immunology, vol.27, issue.1, pp.519-550, 2009.
DOI : 10.1146/annurev.immunol.021908.132612

S. Kezic, G. M. O-'regan, R. Lutter, I. Jakasa, E. S. Koster et al., Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency, Journal of Allergy and Clinical Immunology, vol.129, issue.4, pp.1031-1039, 1031.
DOI : 10.1016/j.jaci.2011.12.989

L. Grine, L. Dejager, C. Libert, and R. E. Vandenbroucke, Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice, The Journal of Immunology, vol.194, issue.11, pp.5094-5102, 2015.
DOI : 10.4049/jimmunol.1403015

H. 11-rabeony, M. Pohin, P. Vasseur, I. Petit-paris, J. F. Jegou et al., IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome, European Journal of Immunology, vol.11, issue.10, pp.2847-2857, 2015.
DOI : 10.1016/S1074-7613(00)80086-2

L. Tortola, E. Rosenwald, B. Abel, H. Blumberg, M. Schafer et al., Psoriasiform dermatitis is driven by IL-36???mediated DC-keratinocyte crosstalk, Journal of Clinical Investigation, vol.122, issue.11, pp.3965-3976, 2012.
DOI : 10.1172/JCI63451DS1
URL : http://www.jci.org/articles/view/63451/files/pdf

L. Van-der-fits, S. Mourits, J. S. Voerman, M. Kant, L. Boon et al., Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis, The Journal of Immunology, vol.182, issue.9, pp.5836-5845, 2009.
DOI : 10.4049/jimmunol.0802999

K. Boniface, C. Diveu, F. Morel, N. Pedretti, J. Froger et al., Oncostatin M Secreted by Skin Infiltrating T Lymphocytes Is a Potent Keratinocyte Activator Involved in Skin Inflammation, The Journal of Immunology, vol.178, issue.7, pp.4615-4622, 2007.
DOI : 10.4049/jimmunol.178.7.4615

C. D. Richards, The Enigmatic Cytokine Oncostatin M and Roles in Disease, ISRN Inflammation, vol.85, issue.12, pp.512103-512104
DOI : 10.1016/j.stem.2011.08.013

H. M. Hermanns, Oncostatin M and interleukin-31: cytokines, receptors, signal transduction and physiology. Cytokine Growth Factor Rev, pp.545-558, 2015.
DOI : 10.1016/j.cytogfr.2015.07.006

P. C. Heinrich, I. Behrmann, S. Haan, H. M. Hermanns, G. Muller-newen et al., Principles of interleukin (IL)-6-type cytokine signalling and its regulation, Biochemical Journal, vol.374, issue.1, pp.1-20, 2003.
DOI : 10.1042/bj20030407

S. 18-chattopadhyay, E. Tracy, P. Liang, O. Robledo, S. Rose-john et al., Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells, Journal of Biological Chemistry, vol.162, issue.5, pp.3014-3026, 2007.
DOI : 10.1038/sj.onc.1202708

K. Guilloteau, I. Paris, N. Pedretti, K. Boniface, F. Juchaux et al., Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis, J. Immunol, vol.184, pp.5256-5270, 2010.

H. Rabeony, I. Petit-paris, J. Garnier, C. Barrault, N. Pedretti et al., Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1??, TNF?? and Oncostatin M, PLoS ONE, vol.61, issue.7, p.101937, 2014.
DOI : 10.1371/journal.pone.0101937.g005

R. M. Grossman, J. Krueger, D. Yourish, A. Granelli-piperno, D. P. Murphy et al., Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes., Proc. Natl. Acad. Sci, pp.6367-6371, 1989.
DOI : 10.1073/pnas.86.16.6367

K. Turksen, T. Kupper, L. Degenstein, I. Williams, and E. Fuchs, Interleukin 6: insights to its function in skin by overexpression in transgenic mice., Proc. Natl. Acad. Sci, pp.5068-5072, 1992.
DOI : 10.1073/pnas.89.11.5068

M. Fu and G. Wang, Keratin 17 as a therapeutic target for the treatment of psoriasis, Journal of Dermatological Science, vol.67, issue.3, pp.161-165, 2012.
DOI : 10.1016/j.jdermsci.2012.06.008

S. Shibata, Y. Tada, Y. Asano, K. Yanaba, M. Sugaya et al., IL-27 Activates Th1-Mediated Responses in Imiquimod-Induced Psoriasis-Like Skin Lesions, Journal of Investigative Dermatology, vol.133, issue.2, pp.479-488, 2013.
DOI : 10.1038/jid.2012.313
URL : https://doi.org/10.1038/jid.2012.313

J. Lubberts, E. Richards, and C. D. , Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand, Am. J. Pathol, vol.160, pp.1733-1743, 2002.

C. Langdon, C. Kerr, M. Hassen, T. Hara, A. L. Arsenault et al., Murine Oncostatin M Stimulates Mouse Synovial Fibroblasts in Vitro and Induces Inflammation and Destruction in Mouse Joints in Vivo, The American Journal of Pathology, vol.157, issue.4
DOI : 10.1016/S0002-9440(10)64634-2

D. K. Fritz, C. Kerr, R. Fattouh, A. Llop-guevara, W. I. Khan et al., A Mouse Model of Airway Disease: Oncostatin M-Induced Pulmonary Eosinophilia, Goblet Cell Hyperplasia, and Airway Hyperresponsiveness Are STAT6 Dependent, and Interstitial Pulmonary Fibrosis Is STAT6 Independent, The Journal of Immunology, vol.186, issue.2, pp.1107-1118, 2011.
DOI : 10.4049/jimmunol.0903476

P. Guihard, Y. Danger, B. Brounais, E. David, R. Brion et al., Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling, STEM CELLS, vol.74, issue.4, pp.762-772, 2012.
DOI : 10.1086/381715
URL : https://hal.archives-ouvertes.fr/inserm-00668995

I. Goren, H. Kampfer, E. Muller, D. Schiefelbein, J. Pfeilschifter et al., Oncostatin M Expression Is Functionally Connected to Neutrophils in the Early Inflammatory Phase of Skin Repair: Implications for Normal and Diabetes-Impaired Wounds, Journal of Investigative Dermatology, vol.126, issue.3, pp.628-637, 2006.
DOI : 10.1038/sj.jid.5700136

C. Hintzen, C. Haan, J. P. Tuckermann, P. C. Heinrich, and H. M. Hermanns, Oncostatin M-Induced and Constitutive Activation of the JAK2/STAT5/CIS Pathway Suppresses CCL1, but Not CCL7 and CCL8, Chemokine Expression, The Journal of Immunology, vol.181, issue.10, pp.7341-7349, 2008.
DOI : 10.4049/jimmunol.181.10.7341

A. D. Rowan, W. Hui, T. E. Cawston, and C. D. Richards, Adenoviral Gene Transfer of Interleukin-1 in Combination with Oncostatin M Induces Significant Joint Damage in a Murine Model, The American Journal of Pathology, vol.162, issue.6, pp.1975-1984, 2003.
DOI : 10.1016/S0002-9440(10)64330-1

J. P. Giot, I. Paris, P. Levillain, V. Huguier, S. Charreau et al., Involvement of IL-1 and Oncostatin M in Acanthosis Associated With Hypertensive Leg Ulcer, The American Journal of Pathology, vol.182, issue.3, pp.806-818, 2013.
DOI : 10.1016/j.ajpath.2012.11.030

S. Chevalier, M. Fourcin, O. Robledo, J. Wijdenes, A. Pouplard-barthelaix et al., Interleukin-6 Family of Cytokines Induced Activation of Different Functional Sites Expressed by gp130 Transducing Protein, Journal of Biological Chemistry, vol.81, issue.25
DOI : 10.1126/science.1542792

A. M. Lin, C. J. Rubin, R. Khandpur, J. Y. Wang, M. Riblett et al., Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis, The Journal of Immunology, vol.187, issue.1, pp.490-500, 2011.
DOI : 10.4049/jimmunol.1100123
URL : http://www.jimmunol.org/content/jimmunol/187/1/490.full.pdf

J. Seneschal, R. A. Clark, A. Gehad, C. M. Baecher-allan, and T. S. Kupper, Human Epidermal Langerhans Cells Maintain Immune Homeostasis in Skin by Activating Skin Resident Regulatory T Cells, Immunity, vol.36, issue.5, pp.873-884, 2012.
DOI : 10.1016/j.immuni.2012.03.018

K. Boniface, E. Guignouard, N. Pedretti, M. Garcia, A. Delwail et al., A role for T cell-derived interleukin 22 in psoriatic skin inflammation, Clinical & Experimental Immunology, vol.18, issue.3, pp.407-415, 2007.
DOI : 10.4049/jimmunol.173.3.2151

J. Romer, E. Hasselager, P. L. Norby, T. Steiniche, J. Thorn-clausen et al., Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol, J. Invest. Dermatol, vol.121, pp.1306-1311, 2003.

D. B. Trivella, J. R. Ferreira-junior, L. Dumoutier, J. C. Renauld, I. Polikarpov et al., Structure and function of interleukin-22 and other members of the interleukin-10 family, Cellular and Molecular Life Sciences, vol.23, issue.17, pp.2909-2935, 2010.
DOI : 10.1007/s00894-004-0195-8

N. 41-dhingra, A. Shemer, J. Correa-da-rosa, M. Rozenblit, J. Fuentes-duculan et al., Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response, Journal of Allergy and Clinical Immunology, vol.134, issue.2, pp.362-372, 2014.
DOI : 10.1016/j.jaci.2014.03.009

M. Li, P. Hener, Z. Zhang, K. P. Ganti, D. Metzger et al., Induction of Thymic Stromal Lymphopoietin Expression in Keratinocytes Is Necessary for Generating an Atopic Dermatitis upon Application of the Active Vitamin D3 Analogue MC903 on Mouse Skin, Journal of Investigative Dermatology, vol.129, issue.2, pp.498-502, 2009.
DOI : 10.1038/jid.2008.232
URL : https://hal.archives-ouvertes.fr/inserm-00357420

E. Esashi, H. Ito, K. Minehata, S. Saito, Y. Morikawa et al., Oncostatin M deficiency leads to thymic hypoplasia, accumulation of apoptotic thymocytes and glomerulonephritis, European Journal of Immunology, vol.195, issue.6, pp.1664-1670, 2009.
DOI : 10.4049/jimmunol.172.6.3876

M. Tanaka, Y. Hirabayashi, T. Sekiguchi, T. Inoue, M. Katsuki et al., Targeted disruption of oncostatin M receptor results in altered hematopoiesis, Blood, vol.102, issue.9, pp.3154-3162, 2003.
DOI : 10.1182/blood-2003-02-0367

C. Kerr, C. Langdon, F. Graham, J. Gauldie, T. Hara et al., in Mice, Journal of Interferon & Cytokine Research, vol.19, issue.10, pp.1195-1205, 1999.
DOI : 10.1089/107999099313145
URL : https://hal.archives-ouvertes.fr/hal-00687792